InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EB Biotin | Inhibition of myeloid differentiation factor 2 by baicalein protects against ... | 2019 | Phytomedicine. | Chen H. et al. | DOI: 10.1016/j.phymed.2019.152997 |
| Mouse TLR1-9 Agonist kit | The cooperative induction of macrophage activation by fucoidan derived from C... | 2019 | BBRC | Miyazaki Y. et al. | DOI: 10.1016/j.bbrc.2019.06.010 |
| ODN 2395 - TLR9 ligand | Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 ... | 2019 | J Infect. | Zhou X. et al. | DOI: 10.1016/j.jinf.2019.06.007 |
| Quil-A® adjuvant | HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation... | 2019 | J Invest Dermatol. | Bashaw A.A. et al. | DOI: 10.1016/j.jid.2019.03.1162 |
| ssRNA40/LyoVec™ | Targeting IRAK4 disrupts inflammatory pathways and delays tumor development i... | 2020 | Leukemia. | Giménez N. et al. | DOI: 10.1038/s41375-019-0507-8 |
| ODN 2006 (ODN 7909) | Targeting IRAK4 disrupts inflammatory pathways and delays tumor development i... | 2020 | Leukemia. | Giménez N. et al. | DOI: 10.1038/s41375-019-0507-8 |
| Anti-EGFR (Cetuximab biosimilar - IgG1 isotype) | Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/G... | 2019 | Cancer Gene Ther. | Yang S. et al. | DOI: 10.1038/s41417-019-0098-6 |
| Peptide M / Agarose | Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequ... | 2019 | PLoS Pathog. | Fourcade L. et al. | DOI: 10.1371/journal.ppat.1007840 |
| Gardiquimod™ | Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are... | 2019 | J Biol Chem. | Bego M.G. et al. | DOI: 10.1074/jbc.RA119.008481 |
| CL097 | C-Reactive Protein Promotes Inflammation through FcγR-Induced Glycolytic Repr... | 2019 | J Immunol. | Newling M. et al. | DOI: 10.4049/jimmunol.1900172 |
| LTA-SA | KSHV and Staphylococcus aureus co-infection in oral cavities of HIV+ patients... | 2019 | J Infect Dis. | Dai L. et al. | DOI: 10.1093/infdis/jiz249 |
| CL429 | Innate immune memory through TLR2 and NOD2 contributes to the control of Lept... | 2019 | PLoS Pathog. | Santecchia I. et al. | DOI: 10.1371/journal.ppat.1007811 |
| CL429 VacciGrade™ | Innate immune memory through TLR2 and NOD2 contributes to the control of Lept... | 2019 | PLoS Pathog. | Santecchia I. et al. | DOI: 10.1371/journal.ppat.1007811 |
| PANX1 | Destination and consequences of Panx1 and mutant expression in polarized MDCK... | 2019 | Exp Cell Res. | Shum M.G. et al. | DOI: 10.1016/j.yexcr.2019.05.016 |
| Rapamycin | Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabb... | 2019 | Neurobiol Dis. | Del Grosso A. et al. | DOI: 10.1016/j.nbd.2019.05.011 |
| Human TLR1-9 Agonist kit | Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling. | 2019 | Sci Rep. | Flynn C.M. et al. | DOI: 10.1038/s41598-019-43617-5 |
| FK506 | TRPA1 Promotes Cardiac Myofibroblast Transdifferentiation after Myocardial In... | 2019 | Oxid Med Cell Longev. | Li S. et al. | DOI: 10.1155/2019/6408352 |
| Anti-murine TLR2 (clone T2.5) Detection and Neutralizing mAb | Role of Escherichia coli endopeptidases and dd-carboxypeptidases in infection... | 2019 | Microbes Infect. | Mallick S. et al. | DOI: 10.1016/j.micinf.2019.04.007 |
| Recombinant anti-mouse IL-1β antibody | MiR-187-3p mimic alleviates ischemia-reperfusion-induced pain hypersensitivit... | 2019 | Brain Behav Immun. | Li X.Q. et al. | DOI: 10.1016/j.bbi.2019.05.021 |
| ODN 2006 (ODN 7909) | Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN. | 2019 | J Autoimmun. | Dieudonné Y. et al. | DOI: 10.1016/j.jaut.2019.05.002 |